Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07349706 · ClinicalTrials.gov registry record · NA

IMST for Dementia Risk Reduction

A NA study of Anxiety and Blood Pressure, sponsored by Florida State University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07349706: Recruiting NA study of Anxiety and Blood Pressure, sponsored by Florida State University.

NCT07349706 is a NA study of Anxiety and Blood Pressure that is actively recruiting participants, run by Florida State University. The registered enrollment target is 30 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07349706, a NA study of Anxiety and Blood Pressure, is actively recruiting participants, sponsored by Florida State University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Using a 2-arm, RCT approach, the primary goal of the study is to evaluate the feasibility and preliminary efficacy of Inspiratory Muscle Strength Training (IMST) as a non-pharmacologic intervention to reduce cardiovascular and cognitive risks in older adults. Next, investigators will examine secondary effects of IMST on mood, sleep quality, systemic inflammation, and physical/motor function. Finally, investigators will assess participant adherence and acceptability ratings of using an 8-week home-based IMST protocol in a diverse older adult sample.

Primary Outcome

Participants will demonstrate a change in systolic blood pressure (mmHg), assessed as the average of two seated measurements obtained following two consecutive 5-minute rest periods, from baseline to post-intervention.

Interventions

  • DEVICE Inspiratory Muscle Strength Training High-Resistance
  • DEVICE Inspiratory Muscle Strength Training Low-Resistance

Study Locations (1)

Florida

  • Florida State University - Tallahassee

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-11-17
Est. Completion 2026-12
Phase NA
Florida State University

219 total trials

What NCT07349706 shows while recruiting

NCT07349706 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (93% lower).

The record links to 7 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Inspiratory Muscle Strength Training High-Resistance is the first listed.

NCT07349706 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT07349706 about?

NCT07349706 is a clinical study titled "IMST for Dementia Risk Reduction". Using a 2-arm, RCT approach, the primary goal of the study is to evaluate the feasibility and preliminary efficacy of Inspiratory Muscle Strength Training (IMST) as a non-pharmacologic intervention to reduce cardiovascular and cognitive risks in older adults. Next, investigators will examine seconda...

What is the current status of trial NCT07349706?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-11-17. Estimated completion is 2026-12.

What conditions does trial NCT07349706 study?

This clinical trial studies the following conditions: Anxiety, Blood Pressure, Cognitive Function, Depression - Major Depressive Disorder, Sleep Quality.

What interventions are being tested in trial NCT07349706?

The interventions under investigation include: Inspiratory Muscle Strength Training High-Resistance (DEVICE), Inspiratory Muscle Strength Training Low-Resistance (DEVICE).

Who is sponsoring clinical trial NCT07349706?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07349706 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07349706's enrollment target sits among peer trials

30 300th of 364 higher than 55 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07349706, the US trial registry maintained by the National Library of Medicine. NCT07349706 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.